Cargando…
The matrix metalloproteinase inhibitor RS-130830 attenuates brain injury in experimental pneumococcal meningitis
BACKGROUND: Pneumococcal meningitis (PM) is characterized by high mortality and morbidity including long-term neurofunctional deficits. Neuropathological correlates of these sequelae are apoptosis in the hippocampal dentate gyrus and necrosis in the cortex. Matrix metalloproteinases (MMPs) play a cr...
Autores principales: | Liechti, Fabian D, Bächtold, Fabian, Grandgirard, Denis, Leppert, David, Leib, Stephen L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352253/ https://www.ncbi.nlm.nih.gov/pubmed/25890041 http://dx.doi.org/10.1186/s12974-015-0257-0 |
Ejemplares similares
-
Inhibition of matrix metalloproteinases attenuates brain damage in experimental meningococcal meningitis
por: Ricci, Susanna, et al.
Publicado: (2014) -
Metformin mediates neuroprotection and attenuates hearing loss in experimental pneumococcal meningitis
por: Muri, Lukas, et al.
Publicado: (2019) -
Combined effect of non-bacteriolytic antibiotic and inhibition of matrix metalloproteinases prevents brain injury and preserves learning, memory and hearing function in experimental paediatric pneumococcal meningitis
por: Muri, Lukas, et al.
Publicado: (2018) -
Evaluation of neurofilament light chain in the cerebrospinal fluid and blood as a biomarker for neuronal damage in experimental pneumococcal meningitis
por: Le, Ngoc Dung, et al.
Publicado: (2020) -
The CCR5 antagonist maraviroc exerts limited neuroprotection without improving neurofunctional outcome in experimental pneumococcal meningitis
por: Le, Ngoc Dung, et al.
Publicado: (2022)